EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

The role of peripheral serotonin in SARS ‐ CoV ‐2 infectivity, COVID ‐19 treatment and long COVID

Daniel W Thorpe iD, Lauren A Jones iD, Alyce M Martin iD, Rosemary A Coleman, Caitlin Allman, Rochelle A Peterson, Damien J Keating iD

Immunology & Cell Biology · 2026-04 · 104 (4) · 368-376

DOI: 10.1111/imcb.70097 ↗

At a glance

Übersichtsarbeit in Immunology & Cell Biology, published online on 2026-03-08. Written by Daniel W Thorpe and 6 co-authors. Institution: Gut Sensory Systems Group, Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Australia. Major MEDLINE topics: Serotonin, COVID-19, SARS-CoV-2, COVID-19 Drug Treatment. 88 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Gastrointestinal symptoms have emerged as a common, but underappreciated, cause of morbidity in relation to SARS‐CoV‐2 infection and the COVID‐19 pandemic. This manifests as a range of indications including diarrhea, anorexia, nausea, vomiting and abdominal pain. In addition, the gastrointestinal tract may represent a route of viral entry via the epithelial cell layer lining the gut wall. This route of entry could be a significant component of disease pathogenesis, including effects on the nervous system via the gut‐brain axis. In this review, we provide an assessment of the effects of COVID‐19 on the gastrointestinal system, its involvement in disease severity and potential pathways for viral entry and infection in the gastrointestinal tract. We also examine evidence that gut‐derived serotonin is affected by SARS‐CoV‐2 infection, how this may link to symptoms and disease pathogenesis and the potential link to the efficacy of selective serotonin reuptake inhibitors in reducing COVID‐19 severity.

Subjects

MeSH terms (MEDLINE)

SerotoninCOVID-19SARS-CoV-2COVID-19 Drug TreatmentGastrointestinal TractHumansPost-Acute COVID-19 SyndromeSelective Serotonin Reuptake InhibitorsAnimalsVirus Internalization

Author keywords

COVID‐19SARS‐CoV‐2SSRIgastrointestinalserotonin

Substances

SerotoninSelective Serotonin Reuptake Inhibitors

Authors and institutions

  • Gut Sensory Systems Group, Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Australia.

ORCID profiles: Daniel W Thorpe, Lauren A Jones, Alyce M Martin, Damien J Keating

Cite

APA

Thorpe, D. W., Jones, L. A., Martin, A. M., Coleman, R. A., Allman, C., Peterson, R. A., & Keating, D. J. (2026). The role of peripheral serotonin in SARS ‐ CoV ‐2 infectivity, COVID ‐19 treatment and long COVID. Immunology & Cell Biology, 104(4), 368-376. https://doi.org/10.1111/imcb.70097

Vancouver

Thorpe DW, Jones LA, Martin AM, Coleman RA, Allman C, Peterson RA, et al. The role of peripheral serotonin in SARS ‐ CoV ‐2 infectivity, COVID ‐19 treatment and long COVID. Immunology & Cell Biology. 2026;104(4):368-376. doi:10.1111/imcb.70097

BibTeX
@article{Thorpe2026,
  author = {Thorpe, Daniel W and Jones, Lauren A and Martin, Alyce M and Coleman, Rosemary A and Allman, Caitlin and Peterson, Rochelle A and Keating, Damien J},
  title = {The role of peripheral serotonin in SARS ‐ CoV ‐2 infectivity, COVID ‐19 treatment and long COVID},
  journal = {Immunology & Cell Biology},
  year = {2026},
  volume = {104},
  number = {4},
  pages = {368--376},
  doi = {10.1111/imcb.70097}
}
Start for free →